The U.S. Food and Drug Administration has notified healthcare professionals of a study published in the New England Journal of Medicine that found patients taking a widely used antibiotic are at higher risk for potentially deadly heart problems.
The study concerns Zithromax, the brand name for azithromycin, which is commonly prescribed for pneumonia and other common infections. The FDA announcement emphasizes that patients taking the drug shouldn’t stop without talking to their doctors.
According to the FDA announcement, azithromycin belongs to a ...
continue reading...